Approaches to leukemic relapse following bone marrow transplantation.
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000517:prevention & control; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007938:Leukemia / Q000532:radiotherapy / Q000628:therapy*; D008875:Middle Aged; D009181:Mycoses / Q000209:etiology; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D013866:Thioguanine / Q000627:therapeutic use; D014184:Transplantation, Homologous
D006680:HLA Antigens; D003561:Cytarabine; D003520:Cyclophosphamide; D013866:Thioguanine; D003630:Daunorubicin